Insider · CIK 0001376117

Ekman Lars

Reports to the SEC for 8 companies · BRISBANE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001376117

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-15	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Director	AAward	+27K sh	—	—	27,000
2025-05-14	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Director	AAward	+20.2K sh	—	—	20,183
2024-05-15	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-05-17	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-01-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−1,303 sh	$56.98	−$74.2K	1,845
2023-01-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−1,523 sh	$58.67	−$89.4K	322
2023-01-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−3,411 sh	$54.15	−$185K	12,666
2023-01-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−6,621 sh	$56.33	−$373K	3,148
2023-01-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−10 sh	$59.46	−$594.6	312
2023-01-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−2,897 sh	$55.35	−$160K	9,769
2023-01-03	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Director	MExercise/Conversion	+15.8K sh	$6.41	+$101K	16,077
2023-01-03	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15.8K sh	—	—	0
2023-01-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−69 sh	$60.85	−$4,198.422	243
2022-12-01	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−6,021 sh	$62.12	−$374K	243
2022-12-01	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15.8K sh	—	—	15,834
2022-12-01	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−9,813 sh	$61.28	−$601K	6,264
2022-12-01	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Director	MExercise/Conversion	+15.8K sh	$6.41	+$101K	16,077
2022-11-01	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−3,312 sh	$64.26	−$213K	1,904
2022-11-01	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15.8K sh	—	—	31,668
2022-11-01	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−1,661 sh	$64.94	−$108K	243
2022-11-01	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Director	MExercise/Conversion	+15.8K sh	$6.41	+$101K	16,076
2022-11-01	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−9,143 sh	$62.01	−$567K	6,933
2022-11-01	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−1,717 sh	$62.91	−$108K	5,216
2022-10-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−6,355 sh	$62.10	−$395K	1,936
2022-10-03	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−15.8K sh	—	—	47,501
2022-10-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−1,693 sh	$62.96	−$107K	243
2022-10-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−4,277 sh	$61.07	−$261K	8,291
2022-10-03	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−3,508 sh	$60.32	−$212K	12,568
2022-10-03	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Director	MExercise/Conversion	+15.8K sh	$6.41	+$101K	16,076
2022-09-28	PRTAPROTHENA CORP PUBLIC LTD COM Exercise/Conversion	Director	MExercise/Conversion	+31.7K sh	$6.41	+$203K	31,909
2022-09-28	PRTAPROTHENA CORP PUBLIC LTD COS Sale	Director	SSale	−31.7K sh	$48.09	−$1.52M	243
2022-09-28	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−31.7K sh	—	—	63,334
2022-06-27	AMRNAMARIN CORP PLC\UK · Stock Option (Right to Buy)A Award	Director	AAward	+116K sh	—	—	115,919
2022-06-27	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsA Award	Director	AAward	+93.8K sh	—	—	93,750
2022-06-24	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,245 sh	—	—	6,245
2022-06-24	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,300 sh	—	—	17,745
2022-05-18	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-06-24	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,125 sh	—	—	4,125
2021-06-24	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+2,145 sh	—	—	14,445
2021-06-14	AMRNAMARIN CORP PLC\UK · Stock Option (Right to Buy)A Award	Director	AAward	+48.5K sh	—	—	48,506
2021-06-14	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsA Award	Director	AAward	+38K sh	—	—	38,000
2021-05-19	PRTAPROTHENA CORP PUBLIC LTD CO · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD CO · Employee Stock Option (Right to Buy)A Award	Director	AAward	+6,315 sh	—	—	6,315
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD CO · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD CO · Employee Stock Option (Right to Buy)A Award	Director	AAward	+8,426 sh	—	—	8,426
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD CO · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD CO · Employee Stock Option (Right to Buy)A Award	Director	AAward	+9,803 sh	—	—	9,803
2021-02-12	PRTAPROTHENA CORP PUBLIC LTD CO · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2020-07-13	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsA Award	Director	AAward	+28.7K sh	—	—	28,702
2020-07-13	AMRNAMARIN CORP PLC\UK · Stock Option (Right to Buy)A Award	Director	AAward	+36.7K sh	—	—	36,739

Recent filings

Accepted (ET)
May 154
Ekman Lars0000905148-26-002469
SEC(opens sec.gov)
May 164
Ekman Lars0000905148-25-001831
SEC(opens sec.gov)
May 174
Ekman Lars0000905148-24-001536
SEC(opens sec.gov)
May 194
Ekman Lars0001140361-23-025828
SEC(opens sec.gov)
Jan 54
Ekman Lars0001567619-23-000574
SEC(opens sec.gov)
Dec 24
Ekman Lars0001140361-22-044319
SEC(opens sec.gov)
Nov 34
Ekman Lars0001140361-22-039911
SEC(opens sec.gov)

Companies

Address

C/O PROTHENA BIOSCIENCES INC 1800 SIERRA POINT PARKWAY

BRISBANE, CA, 94005